Humacyte HUMA
NASDAQ HUMA
$0.65 -0.03 (-4.92%)
As of: Aug 21, 2026 · 3:42 PM EDT

Humacyte (HUMA) EBT Margin Growth (1y) (2021 - 2026)

Humacyte (HUMA) EBT Margin Growth (1y) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 138.71 Bn 130.86 Bn 2.84 Bn -153.00
2 Regeneron Pharmaceuticals 85.60 Bn 77.60 Bn 3.93 Bn -571.00
3 Argenx Se 64.82 Bn 59.63 Bn 1.37 Bn 546.00
4 Moderna 57.92 Bn 52.79 Bn 52.00 Mn 4,709.00
5 BeOne Medicines 41.88 Bn 36.78 Bn 1.53 Bn 1,076.00
6 Alnylam Pharmaceuticals 31.46 Bn 28.15 Bn 992.69 Mn 1,911.00
7 BioNTech SE 27.96 Bn 9.57 Bn 668.28 Mn -2,507.00
8 Insmed 27.35 Bn 26.19 Bn 358.27 Mn 29,565.00
9 Royalty Pharma 27.27 Bn 26.43 Bn - -392.00
10 Humacyte 151.73 Mn 151.73 Mn -825,000.00 331,981.00

Historic Data

Download Data
DateValue
Jun 30, 2026 331,981.00
Mar 31, 2026 -129,085.00
Sep 30, 2021 -1.12 Mn